Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1
- 23 August 2000
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 38 (9) , 793-799
- https://doi.org/10.1016/s0278-6915(00)00065-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mycotoxin-Induced Elevation of Free Sphingoid Bases in Precision-Cut Rat Liver Slices: Specificity of the Response and Structure–Activity RelationshipsToxicology and Applied Pharmacology, 1997
- Toxicity of fumonisin B1 to B6C3F1 mice: A 14-day gavage studyFood and Chemical Toxicology, 1997
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Time- and dose-response effects of the mycotoxin, fumonisin B1 on sphingoid base elevations in precision-cut rat liver and kidney slicesToxicology in Vitro, 1996
- Fumonisins, mycotoxins of increasing importance: Their nature and their effectsPharmacology & Therapeutics, 1996
- Distribution and excretion of [14C] fumonisin B1 in male sprague‐dawley ratsNatural Toxins, 1993
- Toxicity and carcinogenicity of the Fusanum monilzforine metabolite, fumonisin B1, in ratsCarcinogenesis: Integrative Cancer Research, 1991
- Pulmonary Edema and Hydrothorax in Swine Produced by Fumonisin B1, a Toxic Metabolite of Fusarium MoniliformeJournal of Veterinary Diagnostic Investigation, 1990
- Quantitation of free sphingosine in liver by high-performance liquid chromatographyAnalytical Biochemistry, 1988
- Animal glycolipids as attachment sites for microbesChemistry and Physics of Lipids, 1986